Table 5.

Change of VA after administration (SS)

VA	Treatment groupa	Control groupb	t-value	P-value
Baseline, mean ± SD	0.50 ± 0.26	0.54 ± 0.27	1.046	0.297
Visit 1 (3rd day), mean ± SD	0.52 ± 0.27	0.56 ± 0.24	0.999	0.319
Visit 2 (7th day), mean ± SD	0.57 ± 0.28	0.61 ± 0.23	1.088	0.278
Visit 3 (14th day), mean ± SD	0.63 ± 0.27	0.68 ± 0.23	1.540	0.125
Visit 4 (21st day), mean ± SD	0.69 ± 0.29	0.74 ± 0.20	1.245	0.215

Notes:

^aTreatment group = ganciclovir in situ ophthalmic gel group;

^bcontrol group = ganciclovir ophthalmic gel group.

Abbreviations: VA, visual acuity; SS, safety analysis set; SD, standard deviation.